Intranasal Drug Delivery Devices Market Poised to Witness High Growth Owing to Increased Adoption of Self-Administered Drugs

 
Intranasal Drug Delivery Devices market Demand

The intranasal drug delivery devices market offers a non-invasive alternate route of drug delivery to bypass first-pass metabolism. Intranasal drug delivery provides direct entry of drugs into systemic circulation, facilitates quick absorption, and enables self-administration of drugs. Intranasal drug delivery devices deliver medications to treat various conditions including allergies, migraines, nausea, pain, and infections. The market has benefited from advantages such as rapid onset of action, ease of administration even by untrained personnel, and delivery of large molecules that are difficult to absorb through other routes.

The Global Intranasal Drug Delivery Devices Market is estimated to be valued at US$ 3.27 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Intranasal Drug Delivery Devices are GlaxoSmithKline PLC, AstraZeneca PLC, Pfizer, Inc., OptiNose, Inc., 3M Company, Becton, Dickinson and Company, Promius Pharma, LLC, Cadila Pharmaceuticals Ltd., B.F. Ascher & Company, Inc., PendoPharm, Inc., Douglas Pharmaceuticals Ltd., ENT Technologies Pty. Ltd., NAVEH Pharma Ltd., Novartis AG, Neurelis, Inc., Aptargroup, Inc. These players are focusing on new product launches and approvals to gain a competitive edge in the market.

The key opportunities in the Intranasal Drug Delivery Devices market Demand include a large patient pool suffering from conditions requiring self-administration of drugs and technological innovations to improve delivery and enhance patient compliance.

Global expansion remains a key strategy for leading players. The market is expected to observe high demand in Asia Pacific and Latin America due to growing healthcare infrastructure and increasing awareness.

Market Drivers

The increased adoption of self-administered drugs is anticipated to drive the demand for intranasal drug delivery devices market. Intranasal drugs allow for self-administration by patients, eliminating the need for trained healthcare professionals. This provides independence to patients and flexibility in emergency situations.

Market Restraints

Nasal membrane irritation is a major concern associated with intranasal drug delivery. Frequent and long-term use of nasal sprays can cause thinning, drying, inflammation, and discoloration of nasal tissues which reduces effectiveness over time. This limits long-term usage of intranasal sprays.

Segment Analysis

The intranasal drug delivery devices market can be segmented based on dosage form, container type, application, end-users and distribution channels. Among dosage forms, the sprays segment dominate the market and is expected to continue its dominance over the forecast period. This is because sprays allow for needle-free delivery of drugs, provide for convenient self-administration and afford precise control and targeting of drug delivery.

Based on container type, the pressurized canisters segment lead the market owing to their popularity in over-the-counter products as well as their ability to target the upper posterior region of the nasal cavity for effective systemic delivery. Multidose devices are also expected to grow at a faster rate due to rising adoption of portable reusable devices.

The allergy treatment segment accounts for the highest share in the intranasal drug delivery devices market by application. This is attributed to growing allergy rates worldwide coupled with greater uptake of intranasal administration instead of oral formulations to avoid liver metabolism and gastrointestinal degradation.

Global Analysis

Regionally, North America holds the largest share of the Intranasal Drug Delivery Devices Market Regional Analysis and is estimated to continue dominating over the forecast period. This is driven by rising prevalence of allergic conditions, growing preference for self-administration of medications, and advancements in device development by major players in the region. Europe holds the second largest share and is expected to experience notable growth due to increasing research activities evaluating intranasal delivery potential for conditions like Parkinson’s disease. The Asia Pacific region is likely to grow at the fastest pace owing to improving access to healthcare and rising patient population seeking non-invasive treatment options. Within Asia Pacific, China and India are projected to emerge as high potential markets.

Get More Insights On- Intranasal Drug Delivery Devices Market

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.

(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/)


Comments

Popular posts from this blog

Reach Stackers: Amazing Machines Transforming Material Handling at Port Terminals

External Fixation: A Revolutionary Method for Fracture Treatment

The Pre-owned Medical Devices Market is embracing trends by increasing adoption of refurbished medical devices